Abnormal anisotropic diffusion properties in pediatric myelomeningocele patients treated with fetal surgery: an

Francesco T Mangano1,2, Charles B Stevenson1,2, Usha Nagaraj2,3

  • 1Division of Pediatric Neurosurgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Insights

Diffusion tensor imaging (DTI) revealed white matter abnormalities in pediatric patients who underwent fetal repair for myelomeningocele (MMC). These DTI findings may serve as biomarkers for hydrocephalus assessment in this population.

Area of Science:

  • Neuroimaging
  • Pediatric Neurology
  • Developmental Biology

Background:

  • Myelomeningocele (MMC) repair in utero aims to improve outcomes but may impact brain development.
  • Understanding white matter microstructural changes post-fetal MMC repair is crucial for long-term patient management.

Purpose of the Study:

  • To investigate white matter microstructural abnormalities using diffusion tensor imaging (DTI) in pediatric patients following fetal repair for myelomeningocele (MMC).

Main Methods:

  • Retrospective analysis of DTI data from 8 pediatric patients with prenatal MMC repair and 8 age-matched controls.
  • Calculated fractional anisotropy (FA) and mean diffusivity (MD) in the genu of corpus callosum (gCC) and posterior limb of internal capsule (PLIC).
  • Assessed ventricle size using the fronto-occipital horn ratio (FOHR) and compared DTI values between groups using paired t-tests.

Main Results:

  • Patients with prenatal MMC repair exhibited significantly larger ventricles (FOHR) compared to controls (p < 0.001).
  • Significant differences in DTI measures were observed in the gCC, with lower FA and higher MD in the patient group (p = 0.007 and 0.003, respectively).
  • A trend towards increased MD was noted in the PLIC of patients compared to controls (p = 0.065).

Conclusions:

  • Diffusion tensor imaging (DTI) demonstrates white matter microstructural abnormalities in pediatric patients after fetal MMC repair.
  • DTI's sensitivity in detecting these abnormalities suggests its potential as an imaging biomarker for hydrocephalus assessment.
  • These findings can aid in optimizing treatment decisions for hydrocephalus in this patient population.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
261
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
250
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Diffusion01:12

Diffusion

Diffusion is the passive movement of substances down their concentration gradients—requiring no expenditure of cellular energy. Substances, such as molecules or ions, diffuse from an area of high concentration to an area of low concentration in the cytosol or across membranes. Eventually, the concentration will even out, with the substance moving randomly but causing no net change in concentration. Such a state is called dynamic equilibrium, which is essential for maintaining overall...
216.5K